EAPP: Gatekeeper at the crossroad of apoptosis and p21-mediated cell-cycle arrest

Oncogene

Volumn 30, Issue 23, 2011, Pages 2679-2690

  Andorfer, P ^a   Rotheneder, H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

apoptosis; cell cycle arrest; DNA damage; EAPP; p21

Indexed keywords

E2F ASSOCIATED PHOSPHOPROTEIN; NUCLEAR PROTEIN; PHOSPHOPROTEIN; PROTEIN P21; PROTEIN P53; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL STRESS; CELL TRANSFORMATION; DNA DAMAGE; HOMEOSTASIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSCRIPTION INITIATION; UPREGULATION;

APOPTOSIS; BINDING SITES; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; DNA-BINDING PROTEINS; E2F1 TRANSCRIPTION FACTOR; FLOW CYTOMETRY; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GREEN FLUORESCENT PROTEINS; HUMANS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS;

PYRONIA TITHONUS;

EID: 79958269098     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.639     Document Type: Article

References (51)

1. Abbas T, Dutta A. (2009). p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9: 400-414.
2. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumuro K et al. (1999). Apoptosis inhibitory activity of cytoplasmic p21 (Cip1/WAF1) in monocytic differentiation. EMBO J 18: 1223-1234. (Pubitemid 29110307)
3. Baptiste-Okoh N, Barsotti AM, Prives C. (2008). Caspase 2 is both required for p53-mediated apoptosis and downregulated by p53 in a p21-dependent manner. Cell Cycle 7: 1133-1138. (Pubitemid 351749262)
4. Blagosklonny MV. (2002). Are p27 and p21 cytoplasmic oncoproteins? Cell Cycle 1: 391-393.
5. Cazzalini O, Scovassi AI, Savio M, Stivala LA, Prosperi E. (2010). Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat Res 704: 12-20.
6. Chen J, Jackson PK, Kirschner MW, Dutta A. (1995). Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374: 386-388.
7. Chen J, Saha P, Kornbluth S, Dynlacht BD, Dutta A. (1996). Cyclin-binding motifs are essential for the function of p21CIP1. Mol Cell Biol 16: 4673-4682. (Pubitemid 26272120)
8. Chen K, Ou XM, Wu JB, Shih JC. (2010). Transcription factor EAPP, R1 and Sp1 cooperatively regulate glucocorticoid activation of monoamine oxidase B. Mol Pharmacol (e-pub ahead of print).
9. Delavaine L, La Thangue NB. (1999). Control of E2F activity by p21Waf1/Cip1. Oncogene 18: 5381-5392.
10. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. (1995). Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
11. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al 1993 WAF1, a potential mediator of p53 tumor suppression. Cell 75 817-825. (Pubitemid 23346378)
12. Flores-Rozas H, Kelman Z, Dean FB, Pan ZQ, Harper JW, Elledge SJ et al. (1994). Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. Proc Natl Acad Sci USA 91: 8655-8659. (Pubitemid 24273723)
13. Gartel AL, Radhakrishnan SK. (2005). Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res 65: 3980-3985. (Pubitemid 40775632)
14. Gartel AL, Tyner AL. (2002). The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1: 639-649.
15. Giono LE, Manfredi JJ. (2006). The p53 tumor suppressor participates in multiple cell cycle checkpoints. J Cell Physiol 209: 13-20. (Pubitemid 44318664)
16. Goda K, Bacso Z, Szabo G. (2009). Multidrug resistance through the spectacle of P-glycoprotein. Curr Cancer Drug Targets 9: 281-297.
17. Goubin F, Ducommun B. (1995). Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor. Oncogene 10: 2281-2287.
18. Gros P, Ben Neriah YB, Croop JM, Housman DE. (1986). Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 323: 728-731. (Pubitemid 17172974)
19. Gutmann DA, Ward A, Urbatsch IL, Chang G, van Veen HW. (2010). Understanding polyspecificity of multidrug ABC transporters: closing in on the gaps in ABCB1. Trends Biochem Sci 35: 36-42.
20. Hartwell LH, Weinert TA. (1989). Checkpoints: controls that ensure the order of cell cycle events. Science 246: 629-634. (Pubitemid 19283354)
21. Hauser C, Schuettengruber B, Bartl S, Lagger G, Seiser C. (2002). Activation of the mouse histone deacetylase 1 gene by cooperative histone phosphorylation and acetylation. Mol Cell Biol 22: 7820-7830. (Pubitemid 35217293)
22. Helin K, Wu CL, Fattaey AR, Lees JA, Dynlacht BD, Ngwu C et al. (1993). Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev 7: 1850-1861. (Pubitemid 23312940)
23. Idziorek T, Estaquier J, De Bels F, Ameisen JC. (1995). YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability. J Immunol Methods 185: 249-258.
24. Janicke RU, Sohn D, Essmann F, Schulze-Osthoff K. (2007). The multiple battles fought by anti-apoptotic p21. Cell Cycle 6: 407-413. (Pubitemid 46393442)
25. Karakas B, Weeraratna AT, Abukhdeir AM, Konishi H, Gustin JP, Vitolo MI et al. (2007). P21 gene knock down does not identify genetic effectors seen with gene knock out. Cancer Biol Ther 6: 1025-1030. (Pubitemid 351574952)
26. Kawasaki T, Tomita Y, Bilim V, Takeda M, Takahashi K, Kumanishi T. (1996). Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21/WAF1/CIP1 and/or p53 gene alterations. Int J Cancer 68: 501-505. (Pubitemid 26414506)
27. Kitaura H, Shinshi M, Uchikoshi Y, Ono T, Iguchi-Ariga SM, Ariga H. (2000). Reciprocal regulation via protein-protein interaction between c-Myc and p21(cip1/waf1/sdi1) in DNA replication and transcription. J Biol Chem 275: 10477-10483. (Pubitemid 30202109)
28. Kornberg RD. (2007). The molecular basis of eukaryotic transcription. Proc Natl Acad Sci USA 104: 12955-12961. (Pubitemid 351737575)
29. Lagger G, Doetzlhofer A, Schuettengruber B, Haidweger E, Simboeck E, Tischler J et al. (2003). The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene. Mol Cell Biol 23: 2669-2679. (Pubitemid 36403069)
30. Li AG, Piluso LG, Cai X, Gadd BJ, Ladurner AG, Liu X. (2007a). An acetylation switch in p53 mediates holo-TFIID recruitment. Mol Cell 28: 408-421. (Pubitemid 350030559)
31. Li B, Carey M, Workman JL. (2007b). The role of chromatin during transcription. Cell 128: 707-719. (Pubitemid 46273570)
32. Novy M, Pohn R, Andorfer P, Novy-Weiland T, Galos B, Schwarzmayr L et al. (2005). EAPP, a Novel E2F Binding Protein That Modulates E2F-dependent Transcription. Mol Biol Cell 16: 2181-2190. (Pubitemid 40632204)
33. Peng J, Zhu Y, Milton JT, Price DH. (1998). Identification of multiple cyclin subunits of human P-TEFb. Genes Dev 12: 755-762. (Pubitemid 28134306)
34. Perucca P, Cazzalini O, Madine M, Savio M, Laskey RA, Vannini V et al. (2009). Loss of p21 CDKN1A impairs entry to quiescence and activates a DNA damage response in normal fibroblasts induced to quiescence. Cell Cycle 8: 105-114.
35. Phillips AC, Vousden KH. (2001). E2F-1 induced apoptosis. Apoptosis 6: 173-182. (Pubitemid 32423726)
36. Pietenpol JA, Stewart ZA. (2002). Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology 181-182: 475-481. (Pubitemid 36015741)
37. Qin XQ, Livingston DM, Kaelin Jr WG., Adams PD. (1994). Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci USA 91: 10918-10922. (Pubitemid 24349596)
38. Rayter S, Elliott R, Travers J, Rowlands MG, Richardson TB, Boxall K et al. (2008). A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D. Oncogene 27: 1036-1044. (Pubitemid 351253192)
39. Roninson IB. (2002). Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 179: 1-14. (Pubitemid 34195647)
40. Rotheneder H, Geymayer S, Haidweger E. (1999). Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter. J Mol Biol 293: 1005-1015.
41. Rozan LM, El-Deiry WS. (2007). p53 downstream target genes and tumor suppression: a classical view in evolution. Cell Death Differ 14: 3-9. (Pubitemid 44911889)
42. Schwarzmayr L, Andorfer P, Novy M, Rotheneder H. (2008). Regulation of the E2F-associated phosphoprotein promoter by GC-box binding proteins. Int J Biochem Cell Biol 40: 2845-2853.
43. Shan B, Lee WH. (1994). Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell Biol 14: 8166-8173. (Pubitemid 24373565)
44. Sherr CJ, Roberts JM. (2004). Living with or without cyclins and cyclin-dependent kinases. Genes Dev 18: 2699-2711. (Pubitemid 39507762)
45. Sikorski TW, Buratowski S. (2009). The basal initiation machinery: beyond the general transcription factors. Curr Opin Cell Biol 21: 344-351.
46. Sowa Y, Orita T, Minamikawa S, Nakano K, Mizuno T, Nomura H et al. (1997). Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. Biochem Biophys Res Commun 241: 142-150. (Pubitemid 28033553)
47. Suzuki A, Tsutomi Y, Miura M, Akahane K. (1999). Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21. Oncogene 18: 1239-1244. (Pubitemid 29085997)
48. Waga S, Hannon GJ, Beach D, Stillman B. (1994). The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578. (Pubitemid 24192528)
49. Waldman T, Lengauer C, Kinzler KW, Vogelstein B. (1996). Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381: 713-716. (Pubitemid 26196573)
50. Wu X, Levine AJ. (1994). p53 and E2f-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 91: 3602-3606. (Pubitemid 24139478)
51. Zhu H, Chang BD, Uchiumi T, Roninson IB. (2002). Identification of promoter elements responsible for transcriptional inhibition of polo-like kinase 1 and topoisomerase IIalpha genes by p21 (WAF1/CIP1/SDI1). Cell Cycle 1: 59-66.